149 related articles for article (PubMed ID: 9765343)
21. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
22. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
[TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
24. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
25. Endogenous central kappa-opioid systems augment renal sympathetic nerve activity to maximally retain urinary sodium during hypotonic saline volume expansion.
Gottlieb HB; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2005 Nov; 289(5):R1289-96. PubMed ID: 15976307
[TBL] [Abstract][Full Text] [Related]
26. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
27. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
Chang KJ; Rigdon GC; Howard JL; McNutt RW
J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
[TBL] [Abstract][Full Text] [Related]
28. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
29. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
Zhang H; Torregrossa MM; Jutkiewicz EM; Shi YG; Rice KC; Woods JH; Watson SJ; Ko MC
Eur J Neurosci; 2006 Feb; 23(4):984-94. PubMed ID: 16519663
[TBL] [Abstract][Full Text] [Related]
30. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice.
O'Neill SJ; Collins MA; Pettit HO; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):271-7. PubMed ID: 9223564
[TBL] [Abstract][Full Text] [Related]
31. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats.
Spina L; Longoni R; Mulas A; Chang KJ; Di Chiara G
Behav Pharmacol; 1998 Feb; 9(1):1-8. PubMed ID: 9832942
[TBL] [Abstract][Full Text] [Related]
32. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.
Broom DC; Jutkiewicz EM; Folk JE; Traynor JR; Rice KC; Woods JH
Neuropsychopharmacology; 2002 Jun; 26(6):744-55. PubMed ID: 12007745
[TBL] [Abstract][Full Text] [Related]
33. The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.
Bosse KE; Jutkiewicz EM; Gnegy ME; Traynor JR
Neuropharmacology; 2008 Oct; 55(5):755-62. PubMed ID: 18602932
[TBL] [Abstract][Full Text] [Related]
34. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2006 Jun; 317(3):1337-48. PubMed ID: 16537798
[TBL] [Abstract][Full Text] [Related]
35. BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.
Butelman ER; Negus SS; Gatch MB; Chang KJ; Woods JH
Eur J Pharmacol; 1995 Apr; 277(2-3):285-7. PubMed ID: 7493622
[TBL] [Abstract][Full Text] [Related]
36. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.
Brandt MR; Furness MS; Rice KC; Fischer BD; Negus SS
J Pharmacol Exp Ther; 2001 Nov; 299(2):629-37. PubMed ID: 11602675
[TBL] [Abstract][Full Text] [Related]
37. Renal effects of TAPP, a highly selective mu-opioid agonist.
Gutkowska J; Schiller PW
Br J Pharmacol; 1996 Sep; 119(2):239-44. PubMed ID: 8886404
[TBL] [Abstract][Full Text] [Related]
38. Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats.
Rawls SM; Hewson JM; Inan S; Cowan A
Brain Res; 2005 Jul; 1049(1):61-9. PubMed ID: 15936000
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
40. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
Comer SD; Hoenicke EM; Sable AI; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):888-95. PubMed ID: 8246164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
